What is EyePoint Pharmaceuticals Receivables Turnover?
The Receivables Turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by average Accounts Receivable. An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. EyePoint Pharmaceuticals's Revenue for the
three
months ended in Dec. 2024 was $11.59 Mil. EyePoint Pharmaceuticals's average Accounts Receivable for the
three
months ended in Dec. 2024 was $0.49 Mil.
Hence, EyePoint Pharmaceuticals's Receivables Turnover for the
three
months ended in Dec. 2024 was 23.53.
EyePoint Pharmaceuticals Receivables Turnover Historical Data
The historical data trend for EyePoint Pharmaceuticals's Receivables Turnover can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of EyePoint Pharmaceuticals's Receivables Turnover
For the Biotechnology subindustry, EyePoint Pharmaceuticals's Receivables Turnover, along with its competitors' market caps and Receivables Turnover data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
EyePoint Pharmaceuticals's Receivables Turnover Distribution in the Biotechnology Industry
For the Biotechnology industry and Healthcare sector, EyePoint Pharmaceuticals's Receivables Turnover distribution charts can be found below:
* The bar in red indicates where EyePoint Pharmaceuticals's Receivables Turnover falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. This metric is commonly used to compare companies within the same industry to check whether they are on par with their competitors.
EyePoint Pharmaceuticals Receivables Turnover Related Terms
Thank you for viewing the detailed overview of EyePoint Pharmaceuticals's Receivables Turnover provided by GuruFocus.com. Please click on the following links to see related term pages.
EyePoint Pharmaceuticals Inc is a pharmaceutical company. It is engaged in developing and commercializing ophthalmic products for the treatment of eye diseases. The company has developed FDA-approved sustained-release treatments in ophthalmology. Its pre-clinical development program is focused on using its core Durasert E and Verisome technology platforms to deliver drugs to treat wet age-related macular degeneration, glaucoma, osteoarthritis, and other diseases. Geographically, the firm has operational footprints in the U.S., China, and the UK. It generates a majority of its revenue from the U.S.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
EYPT has been successfully added to your 